Ordena

Cercar

01/01/2022 Propofol sedation administered by cardiologists in echocardiography studies
Li C.-H., González-Salvado V., Bertolí E., Viladés D., Descalzo M., Carreras F., Leta R., Cinca J., Capellades H., Cueva L., Paniagua P.. Propofol sedation administered by cardiologists in echocardiography studies. Rec: Cardioclinics. 2022; 57(1)DOI:10.1016/j.rccl.2021.02.007. PMID:. IF:(Q/D).
01/01/2022 Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
Chastre J., François B., Bourgeois M., Komnos A., Ferrer R., Rahav G., De Schryver N., Lepape A., Koksal I., Luyt C.-E., Sánchez-García M., Torres A., Eggimann P., Koulenti D., Holland T.L., Ali O., Shoemaker K., Ren P., Sauser J., Ruzin A., Tabor D.E., Akhgar A., Wu Y., Jiang Y., DiGiandomenico A., Colbert S., Vandamme D., Coenjaerts F., Malhotra-Kumar S., Timbermont L., Oliver A., Barraud O., Bellamy T., Bonten M., Goossens H., Reisner C., Esser M.T., Jafri H.S., Joannidis M., Klimscha W., De Waele E., Devriendt J., Huberlant V., Depuydt P., Van Boxstael S., Peric M., Kopic J., Hanauer M., Hruby T., Sramek V., Svoboda P., Vymazal T., Novacek M., Annane D., Mira J.-P., Souweine B., Dequin P.-F., Meziani F., Stephan F., Nseir S., Gibot S., Schwebel C., Plantefeve G., Diehl J.-L., Richard C., Lamer C., Klouche K., Jaber S., Zakynthinos E., Filntisis G., Zakynthinos S., Koutsoukou A., Saroglou G., Nikolaou C., Vlachogianni G., Pnevmatikos I., Mandragos K., Kremer I., Rozgonyi Z.D., Marjanek Z., Martin-Loeches I., Singer P., Van Heerden V., Carmeli Y., Povoa P., Seoane A.A., Moura P., Gonzalez F., Ramirez P., Marti A.T., Roca R.F., Oteiza L., Escudero D., Piacentini E., Vera P., Tamayo L., Gallego M.A.G., Canas B.S., Figueira I., Leon R., Korten V., Akova M., Wyncoll D., Whitehouse T., Hopkins P., Sim M., Golan Y., Zervos M., Vazquez J., Cherabuddi K., Smulian G., Rouphael N., Welker J., Sims M., Van Duin D., McCarthy T., Polk C.. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. CRITICAL CARE. 2022; 26(1)DOI:10.1186/s13054-022-04204-9. PMID:36380312. IF:15.100(Q1/2D).
01/01/2022 Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war
Agulnik A., Kizyma R., Salek M., Wlodarski M.W., Pogorelyy M., Oszer A., Yakimkova T., Nogovitsyna Y., Dutkiewicz M., Dalle J.-H., Dirksen U., Eggert A., Fernández-Teijeiro A., Greiner J., Kraal K., Mueller A., Sramkova L., Zecca M., Wise P.H., Mlynarski W., Avula M., Adyrov M.V., Berlanga P., Blackwood C.A., Bouffet E., Czauderna P.S., de Koning L.A., dos Reis Farinha N.J., Foster W.B., Graetz D.E., Gupta S., Holter W., Hough R.E., Kliuchkivska K., Kolenova A., Kolodrubiec J., Moreira D.C., Mukkada S.T., Mykychak I., Raciborska A., Salman Z.S., Sopilnyak A., Tyupa S., Vinitsky A., Wobst N.M., Miller B.A., Rasul S.S., Rodriguez-Galindo C., Alanbousi I., Alexander S.W., Apel A., Bal W.A., Balwierz W.A., Basset-Salom L., Bastardo Blanco D., Bauer K.J., Bayazitov I.T., Bhakta N.H., Bien E.I., Bieniek K.A., Blair S.J., Bodak K.I., Bordeianu I.M., Braganca J.M., Bucurenci M.S., Budny E.B., Budzyn A., Bumgardner C.C., Burditt R.N., Burnside Clapp V.G., Bykov V., Cañete A., Carnelli M., Cela E., Cepowska Z.P., Chaber R., Cherner-Drieux A., Chubata M., Clough H.M., Czernicka - Siwecka J., Czyzewski K., Dashchakovska O., Dembowska-Baginska B.M., Derwich K., Dommett R., Dorosh O., Drabko K.A., Dragomir M.D., Dworzak M., Dyma S., Earl J.D., English M.W., Evseev D.A., Farren B.S., Fedyk N., Ferneza S., Fox Irwin L.E., Galazkowski R.M., Ganieva G., Garanzha V., Gelman M.S., Godzinski J.K., Goeres A.F., Golban R., Griksaitis M.J., Hampel M.A., Hastings S.G., Heenen D.L., Hill M.C., Holiuk I., Hutnik L.M., Irga-Jaworska N., Istomin O., Janczar S.L., Kacharian A., Kalwak K., Karolczyk G.M., Karpenko N.M., Katsubo H., Kaznowska B.J., Kentsis A., Ketteler P., Kienesberger A., Kiselev R., Kizyma Z., Klymniuk H., Kostiuk Y., Kowalik T., Kozlova O., Kozubenko V., Kramar T., Krawczuk-Rybak M., Kulemzina I., Kurkowska P., Kuzyk A.S., Ladenstein R.L., Laguna P.J., Lassaletta A., Lehmberg K., Leontieva O., Liashenko S., Loizou L.G., Lucchetta S.A., Lupo M.W., Lysytsia L., Lysytsia O., Machnik K.A., Mainland J.A., Matczak K.E., Matysiak M.J., Mayeur P., Minervina A.A., Mishkova V., Mizia-Malarz A.J., Morales La Madrid A., Moreno L., Moskvin V.P., Muszynska-Roslan K.M., Nelson A.J., Ociepa T., Oltolini S., Onipko N., Pappas A., Patel A.B., Patrahau A., Pauley J.L., Pavlenko Y., Pavlovych A., Peregud-Pogorzelski J., Perek-Polnik M., Perez V., Perez-Martinez A., Pikman Y., Pitozzi G., Portugal R.G., Posternak V.V., Prete A., Pritchard-Jones K., Radaelli A., Reeves T., Reinhardt D., Reshetnyak A.V., Rider A.J., Rizzari C., Rizzi D., Rodriguez Hermosillo K.G., Ronenko O., Rostowska A.O., Rudko L., Sakaan F.M., Sakhar N., Savva N.N., Scaccaglia D., Schaeffer E.H., Schneider C.U., Scobie N., Semeniuk O., Shevchyk R., Shuler A.I., Shvets S., Skoczen S.P., Smeal W.J., Sokolowski I., Sonkin A.A., Stepanjuk A.I., Spota A., Sterba J., Styczynski J., Svintsova O., Synyuta A.V., Szczepanski T., Szczucinski P.K., Szmyd B.M., Tasso Cereceda M., Teliuk A., Tomanek I., Topping P., Torrent M., Trelinska J., Troyanovska O., Trubnikova E., Tsurkan L.G., Tsymbalyuk-Voloshyn I., Urasinski T.F., Urbanek-Dadela A., Vasilieva N., Vasilyeva A., Verdú-Amorós J., Vilcu-Bajurean N., Vinitsky L., Volpe G., Vorobel O., Wachowiak J.T., Wasiak M.S., Wiedower L.A., Wuenschel L.I., Wysocki M.S., Yurieva M., Zagurska A., Zakharenko S.S., Zakharenko A.V., Zapotochna K., Zawitkowska J.E.. Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war. Lancet Haematology. 2022; 9(9)DOI:10.1016/S2352-3026(22)00259-9. PMID:36055331. IF:(Q/D).
01/01/2022 SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators
Herrero M., Ciruela P., Mendoza S., Mendioroz J., Jané M., Carmona Parcerisa G., Martinez Mateo A.I., Pequeño Saco S., Leon Garcia A.R., Domenech E., Pericas Escalé C., Barrabeig Fabregat I., Rovira Faixa A., Carol Torrades M., Guadalupe Fernandez V., Bes Montalat N., Follia Alsina M.N., Ferras Prats J., Minguell Verges S., Ferrús Serra G., Godoy Garcia P., Alseda Graells M., Parron Bernabe I., Cirera Viladot A., Rius Gibert C., García de Olalla Rizo P., Pérez Albarracín G., Sala Farre M.-R., Clotet Romero L., Herrero Garcia M., Ciruela Navas P., Mallafré-Larrosa M., Mendoza Funes S., Patsi-Bosch G., Martínez-Solanas È., Mendioroz Peña J., Jané Checa M.. SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators. BMC PUBLIC HEALTH. 2022; 22(1)DOI:10.1186/s12889-022-13695-8. PMID:35858841. IF:4.500(Q2/4D).